6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
7m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
12m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
17m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
17m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
17m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

3.72USD+0.08 +2.20%

Closed • Updated at 13:33 GMT+00:00

Market Cap$809.85M

Volume2.35M

Beta0.36

RSI37.70

Gross Margin96.51%

Health TechnologyPharmaceuticals: Major

Cytomx Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

CytomX Therapeutics to Present at Upcoming June Investor Conferences

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update

CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

Community Chat

Ask AI